Amarin Corp Adr (AMRN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Amarin Corp Adr Stock (AMRN) Company Profile

Amarin Corp Adr

Healthcare (1085)

353 1 6699 020

SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2

Prossima data di guadagno

Ultimi documenti SEC

AMRN's Discussions on Twitter

Compare AMRN vs LLY, JNJ, ABBV, MRK, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AMRN Amarin Corp Adr	13.93	289.58M	217.21M	-33.72M	25.63M	-1.6204
LLY Lilly Eli Co	1,123.71	1.07T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	255.16	640.91B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	252.21	453.91B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	129.49	322.95B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	155.66	296.72B	54.66B	13.58B	16.05B	7.0171

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-20	Ripresa	JP Morgan	Underweight
2023-10-25	Downgrade	Jefferies	Buy → Hold
2023-01-06	Aggiornamento	Jefferies	Hold → Buy
2022-05-06	Downgrade	JP Morgan	Neutral → Underweight
2022-05-05	Downgrade	H.C. Wainwright	Buy → Neutral
2022-05-05	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-05-04	Downgrade	Northland Capital	Outperform → Market Perform
2021-05-12	Downgrade	Goldman	Neutral → Sell
2020-09-29	Ripresa	JP Morgan	Neutral
2020-08-26	Iniziato	Piper Sandler	Overweight
2020-05-05	Iniziato	Northland Capital	Outperform
2020-03-31	Downgrade	Goldman	Buy → Neutral
2020-03-31	Downgrade	Jefferies	Buy → Hold
2020-03-31	Aggiornamento	Oppenheimer	Underperform → Perform
2020-03-13	Aggiornamento	Goldman	Neutral → Buy
2020-03-02	Iniziato	Cowen	Outperform
2020-02-18	Aggiornamento	Citigroup	Neutral → Buy
2020-01-06	Iniziato	JP Morgan	Neutral
2019-12-16	Downgrade	Stifel	Buy → Hold
2019-11-20	Iniziato	Oppenheimer	Underperform
2019-11-18	Downgrade	Citigroup	Buy → Neutral
2019-11-15	Reiterato	SVB Leerink	Outperform
2019-10-31	Iniziato	Aegis Capital	Buy
2019-10-15	Iniziato	Goldman	Neutral
2019-08-14	Iniziato	SVB Leerink	Outperform
2019-07-09	Reiterato	Jefferies	Buy
2019-06-17	Iniziato	ROTH Capital	Buy
2019-03-22	Iniziato	Stifel	Buy

Mostra tutto

Amarin Corp Adr Borsa (AMRN) Ultime notizie

Amarin Corp Adr Azioni (AMRN) Dati Finanziari

Amarin Corp Adr (AMRN)

Amarin Corp Adr Stock (AMRN) Company Profile

Compare AMRN vs LLY, JNJ, ABBV, MRK, NVS

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Amarin Corp Adr Borsa (AMRN) Ultime notizie

Amarin Corporation Plc Sponsored ADR Revenue Breakdown – FWB:EH3 - TradingView

Amarin CorpADR (AMRN) Fundamental & Financial Data - Stocktwits

AMRN: Amarin CorpADR Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Bears are Losing Control Over Amarin (AMRN), Here's Why It's a 'Buy' Now - Yahoo Finance

EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma - TradingView

AMRNAmarin Corp ADR Options - Finviz

Amarin Corporation Plc Sponsored ADR Actuals & Estimates (NASDAQ:AMRN) - TradingView

EH3 Forecast — Price Target — Prediction for 2027 - TradingView

Here's Why You Should Add ANIX Stock to Your Portfolio Now - TradingView

Net income before discontinued operations of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView

Price to book ratio of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView

Non-operating income (total) of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView

Current ratio of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView

Free cash flow per share of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView

Diluted earnings per share (diluted EPS) of Amarin Corporation Plc Sponsored ADR – DUS:EH3 - TradingView

Amarin Corporation Plc Sponsored ADR Revenue Breakdown – DUS:EH3 - TradingView

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma - Benzinga

AMRN Technical Analysis | Trend, Signals & Chart Patterns | AMARIN CORP PLC -ADR (NASDAQ:AMRN) - ChartMill

Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer - TradingView

symbol__ Stock Quote Price and Forecast - CNN

Amarin shareholders reject key proposals at annual meeting, limit equity grants - Investing.com

CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised - TradingView

Amarin (NASDAQ: AMRN) investors curb new share issues and limit equity pay tools - Stock Titan

Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales - TradingView

All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy - Yahoo Finance

Amarin (AMRN) Loss Trend Of 24.2% Annually Tests Turnaround Narratives Heading Into Q1 - Sahm

Amarin (NASDAQ:AMRN) Surprises with Revenue Beat but EPS Falls Short Amid Restructuring Costs - ChartMill

Amarin Corp PLC (FRA:EH3) Stock Price, Trades & News - GuruFocus

Amarin Corporation Plc Sponsored ADR Trade Ideas — FWB:EH3 - TradingView

Will Amarin (AMRN) Stock Go Higher | Price at $14.77, Up 0.20%Hot Stock Picks - The Legal Advocate

AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz

Amarin Corporation Plc Sponsored ADR Trade Ideas — SWB:EH3 - TradingView

Amarin (NASDAQ: AMRN) details VASCEPA reach, Recordati deal and $70M savings - Stock Titan

Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss - Finviz

Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 - ChartMill

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights - Finviz

Ex-Amarin CEO Loses Suit Over Ouster After Proxy Fight - Law360

Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com

FDA updates fenofibrate labels to reflect lack of cardiovascular benefit - Investing.com

Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance

Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Finviz

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance

Which stocks are gapping on Tuesday? - ChartMill

KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail

Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Finviz

RCKT Stock Tanks on Patient Death in Danon Disease Study - Barchart.com

CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies - Finviz

Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown

Amarin Corp Adr Azioni (AMRN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a AMRN